DISHMAN

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that as per Code of Conduct for prevention of lnsider Trading adopted by the Company under SEBI (Prohibition of lnsider Trading) Regulations , 2015, the trading window shall remain closed from October 19,2016 to October 29, 2016 (both days inclusive) for all the connected persons.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window shall remain closed from July 26, 2016 to August 05, 2016 (both days inclusive) for all the connected persons.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window shall remain closed from April 22, 2016 to May 21, 2016 (both days inclusive) for all the connected persons.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window shall remain closed from March 05, 2016 to March 13, 2016 (both days inclusive) for all the connected persons.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Employees of the Company shall remain closed from 1st February, 2016 to 7th February, 2016 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Employees of the Company shall remain close from October 8, 2015 to October 31, 2015 (both days inclusive).

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Employees of the Company shall remain close from August 23, 2015 to September 02, 2015 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Persons of the Company shall remain close from August 15, 2015 to August 24, 2015 (both day inclusive). During this period, Directors, Designated Persons and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Persons of the Company shall remain close from July 11, 2015 to July 19, 2015 (both day inclusive). During this period, Directors, Designated Persons and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that due to unavoidable circumstances, the Meeting of Board of Directors of Company which was scheduled to be held on May 25, 2015 is hereby postponed to May 28, 2015. In view of this it has been decided to extend the Window Closure Period till May 30, 2015.(Revised)

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that pursuant to the SEBI (Prohibition of Insider Trading) Regulation, 2015 and SEBI Circular bearing No.CIR/ISD/01/2015 dated 11th May, 2015, the Company has formulated a Code of Conduct for Prevention of Insider Trading. The same has also been disseminated to the employees of the Company for their information and compliance. Enclosed is Code of Practices and Procedure for fair disclosure adopted by the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Persons of the Company shall remain close from May 5, 2015 to May 27, 2015 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the trading window for the Designated Employees of the Company shall remain close from February 2, 2015 to February 14, 2015 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Company.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Date of the Board Meeting has been postponed, instead of November 12, 2014 to November 13, 2014 inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended September 30, 2014. In view of the same, the trading window for the Designated Employees of the Company shall remain close from November 01, 2014 to November 14, 2014 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of th

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange that the Board Meeting of the Company is scheduled to be held on November 12, 2014 inter alia, to consider and take on record the Unaudited Financial Results (Provisional) of the Company for the quarter ended 30th September, 2014. In view of the same, the trading window for the Designated Employees of the Company shall remain closed from 1st November, 2014 to 13th November, 2014 (both days inclusive). During this period, Directors, Designated Employees and their dependents are required not to deal in the shares of the Comp